"Vitamin K" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A lipid cofactor that is required for normal blood clotting. Several forms of vitamin K have been identified: VITAMIN K 1 (phytomenadione) derived from plants, VITAMIN K 2 (menaquinone) from bacteria, and synthetic naphthoquinone provitamins, VITAMIN K 3 (menadione). Vitamin K 3 provitamins, after being alkylated in vivo, exhibit the antifibrinolytic activity of vitamin K. Green leafy vegetables, liver, cheese, butter, and egg yolk are good sources of vitamin K.
Below are MeSH descriptors whose meaning is more general than "Vitamin K".
Below are MeSH descriptors whose meaning is more specific than "Vitamin K".
This graph shows the total number of publications written about "Vitamin K" by people in this website by year, and whether "Vitamin K" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
|Year||Major Topic||Minor Topic||Total|
To return to the timeline, click here.
Below are the most recent publications written about "Vitamin K" by people in Profiles.
Mir T, Sattar Y, Attique HB, Hussain T, Alraies MC, Sheikh M, Qureshi WT. Meta-Analysis of Direct Oral Anticoagulants Compared With Vitamin K Antagonist for Left Ventricle Thrombus. Cardiovasc Revasc Med. 2022 02; 35:141-146.
Holley SL, Green K, Mills M, Detterman C, Rappold MF, Thayer S. Educating Parents on Vitamin K Prophylaxis for Newborns. Nurs Womens Health. 2020 Aug; 24(4):283-293.
Miller MM, Lowe J, Khan M, Azeem MU, Muehlschlegel S, Jun-O'Connell AH, Goddeau RP, Moonis M, Gritters D, Silver B, Henninger N. Clinical and Radiological Characteristics of Vitamin K Versus Non-Vitamin K Antagonist Oral Anticoagulation-Related Intracerebral Hemorrhage. Neurocrit Care. 2019 08; 31(1):56-65.
Ko D, Razouki Z, Otis J, Marulanda-Londo?o E, Hylek EM. Anticoagulation reversal in vitamin K antagonist-associated intracerebral hemorrhage: a systematic review. J Thromb Thrombolysis. 2018 Aug; 46(2):227-237.
Freedman JE, Gersh BJ. Atrial fibrillation and stroke prevention in aging patients: what's good can be even better. Circulation. 2014 Jul 08; 130(2):129-31.
Lopes LC, Spencer FA, Neumann I, Ventresca M, Ebrahim S, Zhou Q, Bhatnagar N, Schulman S, Eikelboom J, Guyatt G. Systematic review of observational studies assessing bleeding risk in patients with atrial fibrillation not using anticoagulants. PLoS One. 2014; 9(2):e88131.
Chai P, Babu K. Toxin-induced coagulopathy. Emerg Med Clin North Am. 2014 Feb; 32(1):53-78.
Loke C, Ali SS, Johari V. Pharmacology of anticoagulants. Dis Mon. 2012 Aug; 58(8):424-30.
Gundberg CM, Lian JB, Booth SL. Vitamin K-dependent carboxylation of osteocalcin: friend or foe? Adv Nutr. 2012 Mar 01; 3(2):149-57.
You JJ, Singer DE, Howard PA, Lane DA, Eckman MH, Fang MC, Hylek EM, Schulman S, Go AS, Hughes M, Spencer FA, Manning WJ, Halperin JL, Lip GYH. Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012 Feb; 141(2 Suppl):e531S-e575S.